Internetiühendust pole — kuvatakse lehe salvestatud versioon.

CDT Equity Inc.

USUSD
← Aktsiafiltri Juurde

CDT Equity Inc. (US:CDT) — Biotechnology: Pharmaceutical Preparations. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 1. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.

Ettevõtte Kohta

Veebileht
cdtequity.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Peakontor
NAPLES, United States
Tegevjuht
James Bligh
Töötajad
4
Ringluses Olevad Aktsiad
6.31 mln seisuga 2026-07-15
Vabalt Kaubeldavad Aktsiad
22 431
Turukapitalisatsioon
763 020 USD
Siseringi Isikud
32.85%
Institutsionaalsed Investorid
0.07%
Tegevusala (SIC)
Pharmaceutical Preparations
FCF
−16.0 mln USD
Võlg
800 tuh USD
Kasum ja FCF — 12 kuu jooksul kuni 30.06.2026 (ettevõtte viimane raport).
NAV
163 USD
Balance sheet date30.06.2026
Assets127 mln USD
− Liabilities23.6 mln USD
= NAV (Ettevõtte Aktsionäride Omakapital)103 mln USD
= Tangible NAV103 mln USD
Aktsiad631 080
NAV per share163 USD
Käegakatsutav NAV Aktsia Kohta163 USD
NAV history
Balance sheet dateNAVNAV per share
30.06.2026103 mln USD163 USD
31.03.2026105 mln USD22.33 USD
31.12.2025−7.17 mln USD−778 USD
30.09.20254.28 mln USD3.35 USD
30.06.20253.53 mln USD1.47 USD
31.03.20253.08 mln USD0.32 USD
31.12.2024−6.79 mln USD−14 735 USD
30.09.2024−9.12 mln USD−0.09 USD
Kirjeldus

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

reklaam

Börsid ja Tikkerid

BörsTikkerValuutaHindTüüp
US USA StocksCDTUSD0.24 -46.67%tavalised aktsiad

Hind 3 Kuu Jooksul

US:CDT · USD
tõususepäev langusepäevViige kursor / puudutage päeva — avamis-, sulgemis-, kõrgeim ja madalaim hind

Suurimad Omanikud

OmanikOsalusAktsiadAruande Kuupäev
Jane Street Group, LLC0.03%6 1192026-06-30
Citadel Advisors Llc0.02%3 2302026-06-30
Virtu Financial LLC0.01%2 7242026-06-30
Geode Capital Management…0.01%1 6742026-06-30
Xtx Topco Ltd0.01%1 2922026-06-30
Financial Management Pro…0.01%1 0012026-06-30
Tower Research Capital L…0%9102026-06-30
Fidelity Concord Street…0%592026-07-31
Fidelity Concord Street…0%82026-07-31